RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Gunjan SharmaTiffany M TranIshu BansalMohammad Sabique BegRuchi BhardwajJaspal BassiYuande TanAmit Kumar JaiswalChristine TsoAyushi JainJay SinghParthaprasad ChattopadhyayArchna SinghAnita ChopraSameer BakhshiDavid CaseroDinesh S RaoJayanth Kumar PPublished in: Journal of experimental & clinical cancer research : CR (2023)
Our data suggest a combined impact of the ETV6::RUNX1 fusion protein and RNA binding protein, IGF2BP1 in activating multiple oncogenic pathways in B-ALL which makes IGF2BP1 and these pathways as attractive therapeutic targets and biomarkers.